Archive for the ‘IDIBAPS’ Category

Monday June 12th, 2017

Aleix Prat, named Board Member of the Breast International Group

Dr. Aleix Prat, Head of the Clinical Oncology Department at Hospital Clínic and of the Translational genomics and targeted therapeutics in solid tumors research team at IDIBAPS, has been named member of the Executive Board of the Breast International Group (BIG). The BIG is an international non-profit organisation that includes more than 56 cooperative groups from around the world, more than 10,000 experts and it is linked to more than 3,000 hospitals. Its main goal is to promote clinical and translational research in breast cancer. The appointment, which represents a recognition to his professional career in this field, took place during the annual meeting of the American Society of Clinical Oncology (ASCO) held in June 2-6 in Chicago. Read the rest of this entry »

Comments Closed
Thursday June 08th, 2017

Josep Dalmau, awarded with the Rey Jaime I prize in the Clinical Medicine category

Dr. Josep Dalmau, Professor ICREA at IDIBAPS, where he leads the clinical and experimental Neuroimmunology team, and consultant of the Neurology Department at Hospital Clínic, has been awarded the Rey Jaime I Prize in the Clinical Medicine category . Dr. Dalmau is also a professor in the Department of Medicine at the Faculty of Medicine and Health Sciences of the University of Barcelona (UB). This is the third consecutive year that a Hospital Clinic-IDIBAPS researcher receives this prestigious award. Read the rest of this entry »

Comments Closed

Categories

Posted in:

Wednesday June 07th, 2017

A small group of neurons modulates the amount of insulin that the pancreas must produce

The brain is key in the regulation of appetite, body weight and metabolism. Specifically, there is a small group of hypothalamus neurons, called POMC, that detect and integrate signals that inform on the energy state of the organism and activate the appropriate physiological responses. These neurons are sensitive to fluctuations in nutrients such as glucose, fatty acids and amino acids.

Now, a research project co-chaired by Marc Claret, at the August Pi i Sunyer Biomedical Research Institute – IDIBAPS, and Antonio Zorzano, at the Institute for Research in Biomedicine (IRB Barcelona), both members of the CIBERDEM network, reveals the connection between POMC neurons at the hypothalamus and the release of insulin by the pancreas and describes new molecular mechanisms involved in this connection. The researchers publish the study in Cell Metabolism and the first authors are Sara Ramírez and Alicia G. Gómez-Valadés, both at IDIBAPS. Read the rest of this entry »

Comments Closed
Tuesday May 02nd, 2017

FreeOx Biotech acquires the rights of two compounds to treat neurological and cardiovascular diseases

Dr. Ángel Chamorro, Head of the Functional Unit of Cerebral Vascular Pathology at Hospital Clínic de Barcelona, ​​has developed two compounds with neuroprotective properties based on reducing the effects of oxidative stress on the body. Hospital Clínic and the Clínic Foundation for Biomedical Research, with the support of the IDIBAPS’s KTT office (Knowledge and Technology Transfer), have signed an exclusive license agreement with FreeOx Biotech for the development and exploitation of this technology. Read the rest of this entry »

Comments Closed
Thursday April 20th, 2017

A study reveals the biological changes in breast cancer between the primary tumor and metastases

A study published in the journal Cancer Research underscores the importance of the molecular characterization of the metastases in breast cancer. Researchers have described, for the first time, that the longer the time from the onset of the tumor to the development of metastasis is, the more aggressive this cancer becomes. They have also shown that between the initial tumor and the metastasis the subtype of breast cancer can change in up to 40% of cases. The work has been coordinated by Aleix Prat, Head of the Oncology Department of the Hospital Clínic, Head of the Translational Genomics team and directed therapies in solid tumors IDIBAPS team and Head of the VHIO Translational Genomics Group. The first author of the study is Juan Miguel Cejalvo, PhD student of the PhD4MD program in the group led by Aleix Prat at IDIBAPS and in the Growth Control and Cancer Metastasis group of the Institute for Research in Biomedicine (IRB Barcelona), led by the ICREA researcher Roger Gomis.

Read the rest of this entry »

Comments Closed
Wednesday April 05th, 2017

Elías Campo takes office as Director of IDIBAPS

Yesterday, Tuesday, April 4th, Elías Campo took office as the new Director of IDIBAPS replacing Ramon Gomis, who has held the position since 2008. The election of the new director was made after an international call and an open selection process. Elías Campo is Research and Innovation Director of Hospital Clínic, Director of the Clinic Foundation and responsible for the group Molecular pathology of lymphoid neoplasms of IDIBAPS. He is also full professor in the Faculty of Medicine and Health Sciences at the University of Barcelona. Read the rest of this entry »

Comments Closed
Page 1 of 7512345...Last »